Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 1999

View Archived Issues

Nycomed Amersham: 1999 half-year highlights include first mention of new product

Evacet/Taxotere combination therapy to be assessed in metastatic breast cancer

Endovasc reaches liposomal VEGF development agreement with Hermes Biosciences

Biomira's BLP25 cancer vaccine tested at higher dose and frequency

Orion: 5 NDAs under review in H1 1999

Gliadel Wafer approved in Germany for recurrent GBM

PolyMASC announces factor VIII research agreement with Bayer

CAT and HGS enter agreement for therapeutic antibody development

Centaur conducts phase IIa trials on two product candidates in Q2 1999

Melatonin antagonist S-22153 blocks phase-advancing effects of melatonin in vivo in mice

Oxigene licenses combretastatin prodrug from Arizona State University

Isotechnika advances development of new immunosuppressant

Texas Biotechnology highlights key developments for first half of 1999

Cordox shows cardioprotective effect during prolonged ischemia

Clot buster eptifibatide now on the market in U.K.

Neuronal calcium channel-modulating compounds from Lilly useful in treating CNS disorders

Potential new flu drugs described by BioCryst

Pfizer reveals new series of nicotinic acetylcholine receptor-modulating agents

Bayer research into metabotropic glutamate receptor ligands proves fruitful

K-252a derivatives with potential application in cancer and neurologic disorders

Quidel acquires Metra Biosystems, expands product line

Novel antibiotic series described in patent literature by HMR

COX-2 inhibitor research continues at Searle

STA-BX909: a promising new agent for BNCT

SunPharm to merge with GelTex

FDA approves Chiroscience's injectable anesthetic

Licensing opportunity from BTG: novel compounds for treating MRSA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...